Bio-Techne (TECH) 10-K Summary — Year Ended Jun 30, 2025
Bio-Techne filed its annual report describing its business and financial results. The company reported growth in revenue and profitability, with cash generated from operations supporting its liquidity.
Key takeaway
Year ended Jun 30, 2025 · FY2025 10-K
Bio-Techne filed its annual report describing its business and financial results. The company reported growth in revenue and profitability, with cash generated from operations supporting its liquidity.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$1.2B
Revenue reported for the fiscal year.
Operating income
$102.3M
Income from operations reported for the year.
Net income
$73.4M
Net income reported for the year.
Operating cash flow
$287.6M
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $1.1B | +18.7% |
| Jun 30, 2023 | $1.1B | +2.8% |
| Jun 30, 2024 | $1.2B | +2.0% |
| Jun 30, 2025 | $1.2B | +5.2% |
Business overview
Bio-Techne is a life sciences company providing tools and reagents for research and clinical diagnostics. The company operates through segments such as biotechnology and diagnostics. It serves customers including researchers and pharmaceutical companies.
Financial performance
Revenue grew compared to the prior year. Operating income and net income both increased, reflecting improved profitability. Operating cash flow remained strong.
Material risks
The company faces risks including competition, regulatory changes, and dependence on key personnel. Global economic conditions and supply chain disruptions may also affect operations. Additionally, the company is exposed to foreign currency fluctuations.
Liquidity and capital
The company maintains a strong liquidity position with cash and investments, supplemented by a revolving credit facility. Management expects to meet its capital requirements through operating cash flow and existing credit.
What to watch
Investors should monitor the company's ability to manage foreign currency exposure and global operations.